Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235300
Status:
COMPLETED
Last Update Posted:
2015-03-18
First Post:
2005-10-06
Brief Title:
An Open-label Prospective Randomized Multi-center Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-05
Start Date Type:
None
Primary Completion Date:
2003-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-06
First Submit QC Date:
October 6 2005
Study First Post Date:
2005-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-17
Last Update Post Date:
2015-03-18
Last Update Post Date Type:
ESTIMATED